These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32002285)

  • 1. Endogenous and exogenous glucocorticoids abolish the efficacy of immune-dependent cancer therapies.
    Ma Y; Yang H; Kroemer G
    Oncoimmunology; 2020; 9(1):1673635. PubMed ID: 32002285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stress-glucocorticoid-TSC22D3 axis compromises therapy-induced antitumor immunity.
    Yang H; Xia L; Chen J; Zhang S; Martin V; Li Q; Lin S; Chen J; Calmette J; Lu M; Fu L; Yang J; Pan Z; Yu K; He J; Morand E; Schlecht-Louf G; Krzysiek R; Zitvogel L; Kang B; Zhang Z; Leader A; Zhou P; Lanfumey L; Shi M; Kroemer G; Ma Y
    Nat Med; 2019 Sep; 25(9):1428-1441. PubMed ID: 31501614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stressing Out about Cancer Immunotherapy.
    He XY; Ng D; Van Aelst L; Egeblad M
    Cancer Cell; 2019 Nov; 36(5):468-470. PubMed ID: 31715130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-inflammatory glucocorticoids: changing concepts.
    Newton R
    Eur J Pharmacol; 2014 Feb; 724():231-6. PubMed ID: 23747654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-inflammatory actions of glucocorticoids: molecular mechanisms.
    Barnes PJ
    Clin Sci (Lond); 1998 Jun; 94(6):557-72. PubMed ID: 9854452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implicating the Role of GILZ in Glucocorticoid Modulation of T-Cell Activation.
    Cannarile L; Delfino DV; Adorisio S; Riccardi C; Ayroldi E
    Front Immunol; 2019; 10():1823. PubMed ID: 31440237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoids and Glucocorticoid-Induced-Leucine-Zipper (GILZ) in Psoriasis.
    Sevilla LM; Pérez P
    Front Immunol; 2019; 10():2220. PubMed ID: 31572404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoids.
    Spies CM; Strehl C; van der Goes MC; Bijlsma JW; Buttgereit F
    Best Pract Res Clin Rheumatol; 2011 Dec; 25(6):891-900. PubMed ID: 22265268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocorticosteroids.
    Barnes PJ
    Handb Exp Pharmacol; 2017; 237():93-115. PubMed ID: 27796513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How Glucocorticoids Affect the Neutrophil Life.
    Ronchetti S; Ricci E; Migliorati G; Gentili M; Riccardi C
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30563002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid-transactivated TSC22D3 attenuates hypoxia- and diabetes-induced Müller glial galectin-1 expression via HIF-1α destabilization.
    Kanda A; Hirose I; Noda K; Murata M; Ishida S
    J Cell Mol Med; 2020 Apr; 24(8):4589-4599. PubMed ID: 32150332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoids and the non-steroidal selective glucocorticoid receptor modulator, compound A, differentially affect colon cancer-derived myofibroblasts.
    Drebert Z; Bracke M; Beck IM
    J Steroid Biochem Mol Biol; 2015 May; 149():92-105. PubMed ID: 25666906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity and sensitivity of glucocorticoid signaling in health and disease.
    Cain DW; Cidlowski JA
    Best Pract Res Clin Endocrinol Metab; 2015 Aug; 29(4):545-56. PubMed ID: 26303082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoid-Induced Leucine Zipper: Fine-Tuning of Dendritic Cells Function.
    Vétillard M; Schlecht-Louf G
    Front Immunol; 2018; 9():1232. PubMed ID: 29915587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of glucocorticoid-induced leucine zipper (GILZ) by macrophages: an anti-inflammatory and immunosuppressive mechanism shared by glucocorticoids and IL-10.
    Berrebi D; Bruscoli S; Cohen N; Foussat A; Migliorati G; Bouchet-Delbos L; Maillot MC; Portier A; Couderc J; Galanaud P; Peuchmaur M; Riccardi C; Emilie D
    Blood; 2003 Jan; 101(2):729-38. PubMed ID: 12393603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms and resistance in glucocorticoid control of inflammation.
    Barnes PJ
    J Steroid Biochem Mol Biol; 2010 May; 120(2-3):76-85. PubMed ID: 20188830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological strategies for improving the efficacy and therapeutic ratio of glucocorticoids in inflammatory lung diseases.
    Newton R; Leigh R; Giembycz MA
    Pharmacol Ther; 2010 Feb; 125(2):286-327. PubMed ID: 19932713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoid therapy for gastrointestinal diseases.
    Triadafilopoulos G
    Expert Opin Drug Saf; 2014 May; 13(5):563-72. PubMed ID: 24742121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo.
    Vayssière BM; Dupont S; Choquart A; Petit F; Garcia T; Marchandeau C; Gronemeyer H; Resche-Rigon M
    Mol Endocrinol; 1997 Aug; 11(9):1245-55. PubMed ID: 9259316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamics of glucocorticoids.
    Strehl C; Spies CM; Buttgereit F
    Clin Exp Rheumatol; 2011; 29(5 Suppl 68):S13-8. PubMed ID: 22018178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.